Andres Forero Selected Research

Andres Forero Research Topics

Disease

39	Neoplasms (Cancer) 11/2020 - 10/2003
37	Breast Neoplasms (Breast Cancer) 11/2020 - 05/2011
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 12/2003
4	Triple Negative Breast Neoplasms 08/2019 - 06/2014
4	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 12/2016
4	Lymphoma (Lymphomas) 11/2018 - 02/2005
3	Neoplasm Metastasis (Metastasis) 11/2018 - 06/2014
3	Melanoma (Melanoma, Malignant) 06/2014 - 12/2006
2	Diarrhea 06/2020 - 01/2017
2	Pathologic Complete Response 01/2020 - 05/2013
2	Nausea 01/2017 - 04/2014
2	Fatigue 01/2017 - 04/2014
1	Hand-Foot Syndrome 06/2020
1	Body Weight (Weight, Body) 11/2018
1	Inflammation (Inflammations) 01/2017
1	Vomiting 01/2017
1	Ascites 12/2016
1	Multiple Myeloma 12/2016
1	Pruritus (Itching) 05/2015
1	Alopecia (Baldness) 05/2015
1	Exanthema (Rash) 05/2015

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 01/2020 - 10/2011
10	Proteins (Proteins, Gene)FDA Link 12/2018 - 07/2004
8	Monoclonal AntibodiesIBA 01/2017 - 12/2003
7	Pharmaceutical PreparationsIBA 11/2017 - 10/2008
6	Trastuzumab (Herceptin)FDA Link 01/2020 - 10/2011
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 10/2011
4	Messenger RNA (mRNA)IBA 01/2020 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2014
4	Rituximab (Mabthera)FDA Link 11/2018 - 12/2003
4	Hormones (Hormone)IBA 01/2017 - 05/2013
4	Glycoproteins (Glycoprotein)IBA 05/2015 - 10/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 10/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 10/2005
3	Letrozole (Femara)FDA LinkGeneric 01/2020 - 05/2013
3	Lapatinib (GW572016)FDA Link 01/2020 - 05/2013
3	Histone Deacetylase InhibitorsIBA 12/2019 - 07/2017
3	RNA (Ribonucleic Acid)IBA 01/2017 - 07/2014
3	Immunoconjugates (Immunoconjugate)IBA 05/2015 - 12/2003
3	ibritumomab tiuxetan (Zevalin)FDA Link 09/2007 - 12/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 10/2011
2	Bevacizumab (Avastin)FDA Link 11/2020 - 08/2013
2	Capecitabine (Xeloda)FDA Link 06/2020 - 06/2016
2	entinostat (MS 275)IBA 12/2019 - 12/2018
2	CateninsIBA 10/2018 - 12/2016
2	Niclosamide FDA Link 10/2018 - 12/2016
2	A-Form DNA (A-DNA)IBA 01/2018 - 07/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 04/2015
2	Anastrozole (Arimidex)FDA LinkGeneric 11/2017 - 08/2017
2	Cyclin-Dependent Kinase 4IBA 11/2017 - 08/2017
2	palbociclibIBA 11/2017 - 08/2017
2	DS-8273aIBA 06/2017 - 01/2017
2	Phenobarbital (Luminal)FDA Link 01/2017 - 04/2015
2	glembatumumab vedotinIBA 05/2015 - 06/2014
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 05/2013
2	Albumin-Bound Paclitaxel FDA Link 08/2013 - 06/2012
2	tigatuzumabIBA 06/2012 - 10/2008
2	DOTA-biotin (90Y-DOTA-biotin)IBA 04/2005 - 07/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2020
1	Liposomes (Liposome)IBA 11/2020
1	ChemokinesIBA 12/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2019
1	LigandsIBA 12/2019
1	pembrolizumabIBA 08/2019
1	Poly Adenosine Diphosphate RiboseIBA 08/2019
1	niraparibIBA 08/2019
1	Histocompatibility Antigens Class IIIBA 02/2019
1	Immunomodulating AgentsIBA 12/2018
1	Immune Checkpoint InhibitorsIBA 11/2018
1	magrolimabIBA 11/2018
1	veliparibIBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	thymidine kinase 1IBA 11/2017
1	Circulating Tumor DNAIBA 10/2017
1	neratinibIBA 10/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2017
1	Goserelin (Zoladex)FDA Link 08/2017
1	MethyltransferasesIBA 07/2017
1	Cell-Free Nucleic AcidsIBA 03/2017
1	salicylamideIBA 12/2016
1	B-Cell Activating FactorIBA 12/2016
1	Bortezomib (Velcade)FDA Link 12/2016
1	tabalumabIBA 12/2016
1	Inotuzumab OzogamicinIBA 08/2016
1	doxifluridineIBA 06/2016
1	Poly (ADP-Ribose) Polymerase-1IBA 04/2015
1	Alkylating AgentsIBA 04/2015
1	ofatumumab FDA Link 04/2015
1	Bendamustine Hydrochloride FDA Link 04/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2014
1	AntigensIBA 06/2014

Therapy/Procedure

20	Therapeutics 01/2020 - 12/2003
13	Drug Therapy (Chemotherapy) 11/2020 - 06/2012
6	Radioimmunotherapy 08/2016 - 12/2003
4	Radiotherapy 01/2017 - 04/2014
3	Biological Therapy 03/2016 - 04/2014
3	Neoadjuvant Therapy 01/2015 - 10/2011
2	Immunotherapy 02/2019 - 02/2008
2	Aftercare (After-Treatment) 10/2017 - 04/2013
1	Lasers (Laser) 01/2016